Cleveland, OH (PRWEB) June 14, 2013
Case Western Reserve University, in collaboration with NDI Medical LLC, SPR™ Therapeutics, and Valtronic, has been awarded a $3 million grant from the Ohio Third Frontier Commission to commercialize a neurostimulation technology platform designed to treat multiple clinical indications with significant unmet needs, including pain and muscle paralysis.
The Ohio Third Frontier Innovation Platform Program connects Ohio companies with the technology development and innovation capabilities of Ohio’s universities. As 2013 Ohio Third Frontier awardees, the collaborating partners will commercialize a revolutionary modular neurostimulation system in development at Case Western Reserve for the past decade. The Cleveland based collaborating partners include NDI Medical, a venture and commercialization firm that funds, develops, and manufactures innovative neurodevice technologies, SPR Therapeutics, a commercialization firm focused on the use of neurodevice technologies to treat joint and limb pain, and Valtronic, a niche “mechatronics” manufacturing solutions company.
“This is an important investment and collaboration for the neurodevice industry, as well as the State of Ohio,” said Geoff Thrope, CEO and co-founder of NDI. “This platform technology will enable us to develop advanced treatments for spinal cord injury, chronic pain and a host of other indications as well as create new neurostimulation companies and jobs in Ohio.”
“Cleveland has been an epicenter of neurostimulation commercialization, largely due to companies such as our partners, NDI Medical and Valtronic, championing this technology,” said Hunter Peckham, PhD, founder of the Cleveland Functional Electrical Stimulation (FES) Center and professor of biomedical engineering at Case Western Reserve.
Peckham founded the FES Center 22 years ago to develop neurodevice technology designed to treat impairments fro
Copyright©2012 Vocus, Inc.
All rights reserved